Clinical Trials Directory

Trials / Completed

CompletedNCT02299557

The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients

A Double Blind Study to Examine the Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
19 (actual)
Sponsor
RDD Pharma Ltd · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

This is an double blinded, cross-over study to determine the effect of Oxymetazoline gel on anal resting pressure and fecal incontinence in patients with spinal cord injury. Approximately 17 subjects are expected to complete this 10 weeks study that will include two treatment periods of 4 weeks each, and one 2 weeks wash out period.

Conditions

Interventions

TypeNameDescription
DRUGOxymetazoline gelOxymetazoline gel applied intra-anally once daily
DRUGPlacebo gelPlacebo gel applied intra-anally once daily

Timeline

Start date
2014-11-01
Primary completion
2015-06-01
Completion
2015-07-01
First posted
2014-11-24
Last updated
2015-07-28

Locations

1 site across 1 country: Hungary

Source: ClinicalTrials.gov record NCT02299557. Inclusion in this directory is not an endorsement.

The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients (NCT02299557) · Clinical Trials Directory